PAO Group, Inc.: PAOG Advances CBD Pharmaceutical Developments Backed By US Patent
Sandusky, Ohio (Newsfile Corp. - April 8, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced a management update on the company s ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on Tuesday, April 13, 2021.
Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.
PAOG is working with